Oneview one project at a time

Chris Stott

Portfolio Manager

On Monday, ASX-listed Irish healthcare company Oneview Healthcare Limited (ASX: ONE) announced a pilot project to measure the impact of a new electronic patient care pathway for prostate cancer patients. The collaborative project, with partners including the University of Oxford, is expected to commence in March 2017. The company said the project may lead to commercialisation opportunities. We believe Oneview will continue to gain market share both domestically and globally through capitalising on their innovative and superior product suite. Shares in Oneview closed flat for the week. We own Oneview as a research-driven investment in WAM Capital and WAM Research.


MORE ON



Chris was the Chief Investment Officer of Wilson Asset Management, having joined the company in 2006. He was also the Portfolio Manager responsible for WAM Capital (ASX:WAM), WAM Research (ASX:WAX), WAM Active (ASX:WAA) and WAM MicroCap (ASX:WMI).

I would like to

Only to be used for sending genuine email enquiries to the Contributor. Livewire Markets Pty Ltd reserves its right to take any legal or other appropriate action in relation to misuse of this service.

Personal Information Collection Statement
Your personal information will be passed to the Contributor and/or its authorised service provider to assist the Contributor to contact you about your investment enquiry. They are required not to use your information for any other purpose. Our privacy policy explains how we store personal information and how you may access, correct or complain about the handling of personal information.